AVITA 10-Q Quarterly Report for Q2 2026
Open PDF
| Stock | Avita Medical Inc (AVH.ASX) |
|---|---|
| Release Time | 7 Aug 2026, 8:26 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
AVITA 10-Q Quarterly Report for Q2 2026
Key Points
- Total revenue increased by 17.7% to $40.95 million for Q2 2026
- Net loss widened to $18.3 million for Q2 2026
- Company faces potential going concern issues due to financial conditions
Full Summary
Avita Medical Inc. released its 10-Q Quarterly Report for Q2 2026, showing a 17.7% increase in total revenue to $40.95 million. Despite the revenue growth, the company's net loss widened to $18.3 million for the quarter. The report also highlights potential going concern issues due to the company's financial conditions. The consolidated balance sheet as of June 30, 2026, shows total assets of $47.8 million and total liabilities of $75.6 million, with stockholders' equity (deficit) at -$27.8 million. The company's financial statements were reviewed by an independent registered public accounting firm, which expressed no opinion on the interim financial statements due to the scope of the review being less than an audit.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In